ANTIBODIES TO CARBAMYLATED PROTEINS AS A BIOMARKER OF RHEUMATOID ARTHRITIS ACTIVITY

Authors

  • Xadjimatova I.Kh. Tashkent State Medical University, Tashkent, Uzbekistan Author
  • Karimov M.Sh. Tashkent State Medical University, Tashkent, Uzbekistan Author

Keywords:

rheumatoid arthritis, (anti-CarP), disease activity, autoantibodies.

Abstract

Antibodies to carbamyl proteins (anti-CarP) are considered a promising immunological biomarker for rheumatoid arthritis. Their detection is associated with increased inflammatory process activity, a more severe course of the disease, and the development of erosive changes in the joints. The special clinical significance of antibodies to carbamyl proteins (anti-CarP) is due to the possibility of their detection in patients with seronegative rheumatoid arthritis, which significantly expands diagnostic potential. It has been established that the presence of these autoantibodies is associated with an unfavorable functional prognosis and an increase in the progression of structural joint lesions. In this regard, anti-CarP can be considered a promising tool for early diagnosis, risk stratification, and prognosis of rheumatoid arthritis.

References

Abrikosov, A. I., and Strukov, A. I. (1953). Pathological anatomy. Part 1. General pathological processes. Medgiz, 107-133.

Balabanova, R. M. (1997). Rheumatoid arthritis. Rheumatic diseases (pp. 257-295).

3. Wang, Z. et al. Protein carbamylation links inflammation, smoking, uremia, and atherogenesis. Nat Med. 13, 1176–1184 (2007). [ DOI ] [ PubMed ] [ Google Scholar ]

4. Winkel, A. et al. Kinetics of carbamyllized hemoglobin in acute renal failure. Nephrol Dial Transplant. 15, 1183–1188 (2000). [ DOI ] [ PubMed ] [ Google Scholar ]

5. Derksen, V.F.A.M., Huizinga, T.V.J., and van der Voode, D. The Role of Autoantibodies in the Pathophysiology of Rheumatoid Arthritis. SeminImmunopathol. 39 (4), 437-446 (2017). [ DOI ] [ Free PMC Article ] [ PubMed ] [ Google Scholar ]

6. Dydykina, I. S., Muraviev, Yu. V., Mamistova, A. I., Novoselova, T. M. (2000). Character of registered side effects occurring in patients during treatment at the Clinic of the Rheumatology Institute of the Russian Academy of Medical Sciences. Scientific and Practical Rheumatology, 4, 46.

7. Kopeva, T. N. (1980). Pathology of rheumatoid arthritis. In A. I. Strukova (ed.), Medicine (pp. 196-205).

8. Coniglio, P. et al. Autoantibodies in inflammatory arthritis. Autoimmune Rev. 15 (7), 673-683 (2016). [ DOI ] [ PubMed ] [ Google Scholar ]

Downloads

Published

2026-04-24